Literature DB >> 5963388

A new oral progestational steroid effective in treating prostatic cancer.

W W Scott, H K Schirmer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5963388

Source DB:  PubMed          Journal:  Trans Am Assoc Genitourin Surg        ISSN： 0065-7204


× No keyword cloud information.
  5 in total

1.  Progestogens and cancer.

Authors: 
Journal:  Br Med J       Date:  1971-02-13

Review 2.  Cyproterone. A review of its pharmacology and therapeutic efficacy in prostate cancer.

Authors:  L B Barradell; D Faulds
Journal:  Drugs Aging       Date:  1994-07       Impact factor: 3.923

3.  Gestagens in the management of prostatic carcinoma.

Authors:  Z Szendröi
Journal:  Int Urol Nephrol       Date:  1984       Impact factor: 2.370

4.  The effects of orchiectomy, oestrogens and cyproterone-acetate on the antithrombin-III concentration in carcinoma of the prostate.

Authors:  E Varnehorst; L Wallentin; B Risberg
Journal:  Urol Res       Date:  1981

5.  Aromatase inhibition in advanced prostatic cancer: preliminary communication.

Authors:  R J Shearer; J H Davies; M Dowsett; P R Malone; A Hedley; D Cunningham; R C Coombes
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.